February 19, 2024 - February 22, 2024

Zenith Drugs IPO Subscription Details

Zenith Drugs IPO Subscription Status Live

Zenith Drugs IPO subscribed 179.18 times. The public issue subscribed 139.28 times in the retail category, 106.72 times in QIB, and 368.77 times in the NII category by February 22, 2024 (Day 4).

Investor Category	Subscription (times)	Shares Offered	Shares Bid for	Total Amount (Rs Cr.)*
Qualified Institutions	106.72	859,200	9,16,97,600	724.41
Non-Institutional Buyers*	368.77	644,800	23,77,82,400	1,878.48
Retail Investors	139.28	1,504,000	20,94,81,600	1,654.90
Employees	[.]	0	0	0
Others	[.]	0	0	0
Total *	179.18	3,008,000	53,89,61,600	4,257.80

Total Application : 130,926 (139.28 times)

Disclaimer: *The total amount is calculated based on the final issue price or the price in the upper price range.

* Market Maker portion of 852,800 equity shares not included.

Zenith Drugs IPO (Day-wise) Subscription Details (times)

Date	QIB	NII*	Retail	Total
Day 1 February 19, 2024	0.00	0.99	3.42	1.92
Day 2 February 20, 2024	3.53	2.50	9.41	6.25
Day 3 February 21, 2024	3.54	7.98	19.42	12.43
Day 4 February 22, 2024	106.72	368.77	139.28	179.18

Zenith Drugs IPO Shares Offered

Zenith Drugs IPO is a public issue of 5,148,800 equity shares. The issue offers 1,504,000 shares to retail investors, 859,200 shares to qualified institutional buyers, and 644,800 shares to non-institutional investors.

Category	Shares Offered	Amount (Rs Cr)	Size (%)
Anchor Investor	1,288,000	10.18	25.02%
Market Maker	852,800	6.74	16.56%
QIB	859,200	6.79	16.69%
NII*	644,800	5.09	12.52%
Retail	1,504,000	11.88	29.21%
Total	5,148,800	40.68	100%

Zenith Drugs IPO Anchor Investor Allocation

A total of 1,288,000 shares at a price of Rs 79 per share will be allotted to the anchor investors.

S.No.	Name of Anchor Investor	No. of Shares Allocated	Bid Price Per Share (Rs.)	Anchor Investor Portion (%)	Total Amount Allocated (Rs.)
1	Chanakya Opportunities Fund 1	128,000	79	9.94	10,112,000
2	Moneywise Financial Services Pvt. Ltd.	128,000	79	9.94	10,112,000
3	Neomile Growth Fund - Series I	190,400	79	14.78	15,041,600
4	Meru Investment Fund PCC-Cell 1	377,600	79	29.32	29,830,400
5	Aries Opportunities Fund Limited	252,800	79	19.63	19,971,200
6	Vikasa India EIF I Fund – Zodiac Global Opportunity Fund	211,200	79	16.4	16,684,800
		1,288,000		100	101,752,000

IPO Investor Categories

Qualified Institutional Buyers (QIB)
Financial Institutions, Banks, FIIs, and Mutual Funds registered with SEBI are called QIBs. In most cases, QIBs represent small investors who invest through mutual funds, ULIP schemes of insurance companies, and pension schemes.
Non-Institutional Investors(NII)
Retail Individual Investors (HNI), NRIs, Companies, Trusts, etc who bid for shares worth more than Rs 2 lakhs are known as Non-institutional bidders (NII). Unlike QIB bidders, they do not need SEBI registration.
NII category has two subcategories:
1. sNII (bids below Rs 10L)
  The Small NII category is for NII investors who bid for shares between Rs 2 lakhs to Rs 10 lakhs. The 1/3 of NII category shares are reserved for the Small NII sub-category. This subcategory is also known as Small HNI (sHNI).
2. bNII (bids above Rs 10L)
  The Big NII category is for NII investors who bid for shares worth more than Rs 10 Lakhs. The 2/3 of NII category shares are reserved for the Big NII subcategory. This subcategory is also known as Big HNI (bHNI).
Retail Individual Investors(RII)
The retail individual investor or NRIs who apply up to Rs 2 lakhs in an IPO are considered as RII reserved category.
Employee (EMP)
A category of eligible employees who have a reserved quota in the IPO.
Others
A category of eligible shareholders or other investors who have a reserved quota in the IPO.

What is the difference between RII, NII, QIB and Anchor Investor?

Disclaimer: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites. The information / data provided here in is for informational purposes only and is provided by Chittorgarh.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. Chittorgarh.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites. Chittorgarh.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. Chittorgarh.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites. The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.

Zenith Drugs IPO Subscription FAQs

The Zenith Drugs IPO is subscribed 179.18 by February 22, 2024.